{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:25:31Z","timestamp":1763684731975,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.canep.2020.101688","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T17:31:25Z","timestamp":1582306285000},"page":"101688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Follicular lymphoma polygenic risk score is associated with increased disease risk but improved overall survival among women in a population based case-control in Los Angeles County California"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6973-887X","authenticated-orcid":false,"given":"Charlie","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun R.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Y.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis D.","family":"Weisenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianning","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan Chun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Neuhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Cozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canep.2020.101688_bib0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.canep.2020.101688_bib0010","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2008-05-154013","article-title":"The presence of <em>TP53<\/em> mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival","volume":"112","author":"O\u2019Shea","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.canep.2020.101688_bib0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1182\/blood-2018-07-865428","article-title":"Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016","volume":"133","author":"Qu","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.canep.2020.101688_bib0020","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.canep.2020.101688_bib0025","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.blre.2018.03.005","article-title":"Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI","volume":"32","author":"Wight","year":"2018","journal-title":"Blood Rev."},{"issue":"5","key":"10.1016\/j.canep.2020.101688_bib0030","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canep.2020.101688_bib0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1992.16","article-title":"Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma","volume":"65","author":"Pezzella","year":"1992","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.canep.2020.101688_bib0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ajh.24701","article-title":"BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab","volume":"92","author":"Huet","year":"2017","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.canep.2020.101688_bib0045","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ajhg.2014.09.004","article-title":"Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA Region","volume":"95","author":"Skibola","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.canep.2020.101688_bib0050","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/1471-2164-13-516","article-title":"A meta-analysis of genome-wide association studies of follicular lymphoma","volume":"13","author":"Skibola","year":"2012","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.canep.2020.101688_bib0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjh.14051","article-title":"Sun sensitivity, indoor tanning and B-cell non-Hodgkin lymphoma risk among Caucasian women in Los Angeles County","volume":"177","author":"Wang","year":"2017","journal-title":"Br. J. Haematol."},{"year":"2009","series-title":"L.A.C.C.S. Program, Procedure Guide","key":"10.1016\/j.canep.2020.101688_bib0060"},{"key":"10.1016\/j.canep.2020.101688_bib0065","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1100\/2011\/373876","article-title":"Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma","volume":"11","author":"Lu","year":"2011","journal-title":"ScientificWorldJournal"},{"issue":"1","key":"10.1016\/j.canep.2020.101688_bib0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajhg.2013.05.020","article-title":"Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk","volume":"93","author":"Foo","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"2605","key":"10.1016\/j.canep.2020.101688_bib0075","article-title":"HLA-DR in cytotoxic t lymphocytes predicts breast Cancer patients\u2019 response to neoadjuvant chemotherapy","volume":"9","author":"Saraiva","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.canep.2020.101688_bib0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.seminoncol.2018.07.005","article-title":"New concepts in follicular lymphoma biology: from BCL2 to epigenetic regulators and non-coding RNAs","volume":"45","author":"Devan","year":"2018","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canep.2020.101688_bib0085","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-19-1504","article-title":"Assessing cancer treatment information using Medicare and hospital discharge data among women with non-Hodgkin lymphoma in a Los Angeles County case-control study","author":"Zhong","year":"2020","journal-title":"Cancer Epidemiol. Biomarkers Prev."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782120300229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782120300229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:26:39Z","timestamp":1761801999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782120300229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":17,"alternative-id":["S1877782120300229"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2020.101688","relation":{},"ISSN":["1877-7821"],"issn-type":[{"type":"print","value":"1877-7821"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follicular lymphoma polygenic risk score is associated with increased disease risk but improved overall survival among women in a population based case-control in Los Angeles County California","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2020.101688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101688"}}